JP MORGAN/CALL/ELI LILLY & CO/710/0.1/21.06.24 | Market Closed - Börse Stuttgart 18:59:50 20/06/2024 BST | ||
| 15.79 EUR | -6.95% |
|
| Current month | +53.90% | ||
| 1 month | +149.05% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 20/06/24 | 15.79 | -6.95% |
| 19/06/24 | 16.97 | +2.60% |
| 18/06/24 | 16.54 | +2.67% |
| 17/06/24 | 16.11 | -1.77% |
| 14/06/24 | 16.4 | +9.70% |
Delayed Quote Börse Stuttgart
Last update June 20, 2024 at 06:59 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | J.P. Morgan |
| WKN | JL91QU |
| ISIN | DE000JL91QU6 |
| Date issued | 10/08/2023 |
| Strike | 710 $ |
| Maturity | Today (-0 Days) |
| Parity | 10 : 1 |
| Emission price | 0.93 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.97 € |
|---|---|
| Lowest since issue | 1.05 € |
| Delta | 0x |
| Omega | 0.000000 |
| Premium | 0x |
| Gearing | 0x |
| Moneyness | 1.248 |
| Difference Strike | -174.3 $ |
| Difference Strike % | -24.55% |
| Intrinsic value | 16.44 |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
886
USD
Average target price
855.4
USD
Spread / Average Target
-3.45%
- Stock Market
- Warrants
- Warrant
